Cargando…
Favipiravir versus other antiviral or standard of care for COVID-19 treatment: a rapid systematic review and meta-analysis
BACKGROUND: The COVID-19 causing coronavirus is an enveloped RNA virus that utilizes an enzyme RNA dependent RNA polymerase for its replication. Favipiravir (FVP) triphosphate, a purine nucleoside analog, inhibits that enzyme. We have conducted this systematic review and meta-analysis on efficacy an...
Autores principales: | Shrestha, Dhan Bahadur, Budhathoki, Pravash, Khadka, Sitaram, Shah, Prajwol Bikram, Pokharel, Nisheem, Rashmi, Prama |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7512218/ https://www.ncbi.nlm.nih.gov/pubmed/32972430 http://dx.doi.org/10.1186/s12985-020-01412-z |
Ejemplares similares
-
Corticosteroids in COVID-19: Is it Rational? A Systematic Review and Meta-Analysis
por: Budhathoki, Pravash, et al.
Publicado: (2020) -
Hydroxychloroquine in COVID-19: The Study Points to Premature Decisions on Efficacy While Bells Ringing for Safety
por: Khadka, Sitaram, et al.
Publicado: (2020) -
Pneumomediastinum and Subcutaneous Emphysema in an Adult Male From Nepal Infected With COVID-19
por: Kafle, Satyasuna, et al.
Publicado: (2021) -
Remdesivir: A potential game-changer or just a myth? A systematic review and meta-analysis()
por: Shrestha, Dhan Bahadur, et al.
Publicado: (2021) -
Vasopressin versus norepinephrine as the first-line vasopressor in septic shock: A systematic review and meta-analysis
por: Sedhai, Yub Raj, et al.
Publicado: (2022)